tiprankstipranks
Novavax (NVAX)
NASDAQ:NVAX
Holding NVAX?
Track your performance easily

Novavax (NVAX) Financial Statements

9,632 Followers

Novavax Financial Overview

Novavax's market cap is currently ―. The company's EPS TTM is $-2.26; its P/E ratio is -3.56; Novavax is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 84.51M$ 415.48M$ 93.86M$ 28.94M$ 22.06M
Gross Profit$ 23.89M$ 369.24M$ 34.65M$ -126.03M$ -76.86M
EBIT$ -119.72M$ 167.19M$ -141.18M-$ -128.61M
EBITDA$ -107.02M$ 178.33M$ -129.03M-$ -117.29M
Net Income Common Stockholders$ -121.30M$ 166.52M$ -147.55M$ -178.39M$ -130.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 909.53M$ 1.05B$ 480.59M$ 568.50M$ 651.10M
Total Assets$ 1.71B$ 1.82B$ 1.35B$ 1.80B$ 1.66B
Total Debt$ 233.31M$ 233.25M$ 229.33M$ 229.08M$ 222.11M
Net Debt$ -676.22M$ -816.32M$ -251.25M$ -339.42M$ -428.99M
Total Liabilities$ 2.24B$ 2.25B$ 2.22B$ 2.51B$ 2.34B
Stockholders Equity$ -526.44M$ -431.71M$ -867.08M$ -716.93M$ -678.35M
Cash Flow-
Free Cash Flow$ -146.17M$ 311.43M$ -90.48M-$ -58.05M
Operating Cash Flow$ -144.80M$ 314.30M$ -83.60M$ -176.78M$ -39.66M
Investing Cash Flow$ 31.91M$ -372.71M$ -7.25M$ -9.08M$ -18.39M
Financing Cash Flow$ -97.00K$ 258.22M$ 5.89M$ 100.39M$ 197.12M
Currency in USD

Novavax Earnings and Revenue History

Novavax Debt to Assets

Novavax Cash Flow

Novavax Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis